AZNC Stock Price and Chart — BCBA:AZNC

Key facts today

AstraZeneca will invest $50 billion in U.S. manufacturing by 2030, including a new facility in Virginia and expansions in several states. The company is managing inventory to mitigate tariff impacts.

AstraZeneca is involved in a patent lawsuit in Delaware, accused by Factor Bioscience of infringing three patents on gene-editing tech for cancer treatments, seeking monetary damages.

AstraZeneca will sell Farxiga for $182 and Airsupra for $249 directly to U.S. cash-paying patients, offering discounts up to 70% starting October 1.

Analyze the impact Analyze the impact

About AstraZeneca PLC

AstraZeneca Plc is a holding company, which engages in the research, development, manufacture, and commercialization of prescription medicines. The company’s history roots back to the year 1913 when Astra business was formed. AstraZeneca was founded in 1999 through the merger of Astra AB and Zeneca Group PLC. The company is headquartered in Cambridge, the United Kingdom.

Check out other big names from the same industry as AZNC.